SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures.
COVID-19
COVID-19 diagnostic testing
Feasability Studies
Rural Population
Journal
Archives of public health = Archives belges de sante publique
ISSN: 0778-7367
Titre abrégé: Arch Public Health
Pays: England
ID NLM: 9208826
Informations de publication
Date de publication:
07 Jul 2021
07 Jul 2021
Historique:
received:
20
07
2020
accepted:
21
06
2021
entrez:
8
7
2021
pubmed:
9
7
2021
medline:
9
7
2021
Statut:
epublish
Résumé
Early in the pandemic, inadequate SARS-CoV-2 testing limited understanding of transmission. Chief among barriers to large-scale testing was unknown feasibility, particularly in non-urban areas. Our objective was to report methods of high-volume, comprehensive SARS-CoV-2 testing, offering one model to augment disease surveillance in a rural community. A community-university partnership created an operational site used to test most residents of Bolinas, California regardless of symptoms in 4 days (April 20th - April 23rd, 2020). Prior to testing, key preparatory elements included community mobilization, pre-registration, volunteer recruitment, and data management. On day of testing, participants were directed to a testing lane after site entry. An administrator viewed the lane-specific queue and pre-prepared test kits, linked to participants' records. Medical personnel performed sample collection, which included finger prick with blood collection to run laboratory-based antibody testing and respiratory specimen collection for polymerase chain reaction (PCR). Using this 4-lane model, 1,840 participants were tested in 4 days. A median of 57 participants (IQR 47-67) were tested hourly. The fewest participants were tested on day 1 (n = 338 participants), an intentionally lower volume day, increasing to n = 571 participants on day 4. The number of testing teams was also increased to two per lane to allow simultaneous testing of multiple participants on days 2-4. Consistent staffing on all days helped optimize proficiency, and strong community partnership was essential from planning through execution. High-volume ascertainment of SARS-CoV-2 prevalence by PCR and antibody testing was feasible when conducted in a community-led, drive-through model in a non-urban area.
Sections du résumé
BACKGROUND
BACKGROUND
Early in the pandemic, inadequate SARS-CoV-2 testing limited understanding of transmission. Chief among barriers to large-scale testing was unknown feasibility, particularly in non-urban areas. Our objective was to report methods of high-volume, comprehensive SARS-CoV-2 testing, offering one model to augment disease surveillance in a rural community.
METHODS
METHODS
A community-university partnership created an operational site used to test most residents of Bolinas, California regardless of symptoms in 4 days (April 20th - April 23rd, 2020). Prior to testing, key preparatory elements included community mobilization, pre-registration, volunteer recruitment, and data management. On day of testing, participants were directed to a testing lane after site entry. An administrator viewed the lane-specific queue and pre-prepared test kits, linked to participants' records. Medical personnel performed sample collection, which included finger prick with blood collection to run laboratory-based antibody testing and respiratory specimen collection for polymerase chain reaction (PCR).
RESULTS
RESULTS
Using this 4-lane model, 1,840 participants were tested in 4 days. A median of 57 participants (IQR 47-67) were tested hourly. The fewest participants were tested on day 1 (n = 338 participants), an intentionally lower volume day, increasing to n = 571 participants on day 4. The number of testing teams was also increased to two per lane to allow simultaneous testing of multiple participants on days 2-4. Consistent staffing on all days helped optimize proficiency, and strong community partnership was essential from planning through execution.
CONCLUSIONS
CONCLUSIONS
High-volume ascertainment of SARS-CoV-2 prevalence by PCR and antibody testing was feasible when conducted in a community-led, drive-through model in a non-urban area.
Identifiants
pubmed: 34233752
doi: 10.1186/s13690-021-00647-8
pii: 10.1186/s13690-021-00647-8
pmc: PMC8261397
doi:
Types de publication
Journal Article
Langues
eng
Pagination
125Subventions
Organisme : NIAID NIH HHS
ID : K24 AI144048
Pays : United States
Organisme : Chan Zuckerberg Biohub Investigator Program
ID : Chan Zuckerberg Biohub Investigator Program
Organisme : Bolinas Community Land Trust
ID : Bolinas Community Land Trust
Organisme : National Institute of Allergy and Infectious Diseases
ID : 5T32AI007641-17
Commentaires et corrections
Type : UpdateOf
Références
Am J Infect Control. 2020 Jun;48(6):731-732
pubmed: 32305432
Emerg Infect Dis. 2020 Jul;26(7):
pubmed: 32364890
Open Forum Infect Dis. 2020 Oct 30;8(1):ofaa531
pubmed: 34109255
Science. 2020 Jun 5;368(6495):1060-1061
pubmed: 32414781
J Korean Med Sci. 2020 Mar 23;35(11):e123
pubmed: 32193904